OSCR

+ Watchlist + Portfolio

Oscar Health, Inc. Class A

GridBrain — Sign in

GridSentinel — Sign in

GridAegis — Sign in

Key Metrics

Previous Close: $32.30
52-Week Range: $10.69 – $33.48
Market Cap: $9.74B
P/E (TTM): 24.86
EPS (TTM): 1.27
Dividend Yield: —

Advanced Metrics

Price/Book: 4.74
PEG Ratio: —
Return on Equity: 34.26%
Return on Assets: 4.47%
Gross Margin: 20.16%
Operating Margin: 7.96%
Profit Margin: 3.60%
Current Ratio: 1.08
Debt/Equity: 0.23
Total Debt: $482.10M
Free Cash Flow: $692.53M
Revenue Growth: 70.40%
Earnings Growth: —
Enterprise Value: $1.66B

OSCR Income statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Revenue	$4.13B	$5.86B	$9.18B	$11.70B
Selling, General & Admin	$1.42B	$1.42B	$1.76B	$2.05B
Pretax Income	-$610.08M	-$267.30M	$33.43M	-$437.30M
Income Tax	-$523.00K	$3.29M	$7.30M	$5.61M
Net Income	-$606.27M	-$270.73M	$25.43M	-$443.15M
Diluted EPS	-2.85	-1.22	0.10	-1.69
Diluted Shares	212.47M	221.66M	265.85M	262.39M

OSCR Balance Sheet statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Cash & Equivalents	$1.56B	$1.87B	$1.53B	$2.77B
Receivables	$1.16B	$494.39M	$672.21M	$598.46M
Total Assets	$4.53B	$3.60B	$4.84B	$6.33B
Long-Term Debt	$298.00M	$298.78M	$299.56M	$430.10M
Total Debt	$298.00M	$298.78M	$299.56M	$430.10M
Total Liabilities	$3.63B	$2.80B	$3.82B	$5.34B
Retained Earnings	-$2.61B	-$2.88B	-$2.85B	-$3.29B
Shareholders' Equity	$890.38M	$803.97M	$1.01B	$977.65M

OSCR Cash Flow statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Operating Cash Flow	$380.35M	-$272.16M	$978.19M	$1.09B
Capital Expenditure	-$29.01M	-$25.58M	-$27.90M	-$36.37M
Free Cash Flow	$351.34M	-$297.74M	$950.30M	$1.06B
Depreciation & Amortisation	$15.28M	$30.69M	$32.15M	$28.89M
Stock-Based Compensation	$112.33M	$159.68M	$109.82M	$87.65M
Investing Cash Flow	-$226.52M	$577.19M	-$1.39B	-$241.06M
Financing Cash Flow	$301.11M	$6.45M	$68.39M	$399.21M
Net Change in Cash	$454.94M	$311.47M	-$340.85M	$1.25B

OSCR Income statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Revenue	$3.05B	$2.86B	$2.99B	$2.81B	$4.65B
Selling, General & Admin	$149.77M	$534.49M	$521.59M	$511.03M	$160.08M
Pretax Income	$288.21M	-$233.54M	-$139.29M	-$352.68M	$698.77M
Income Tax	$12.71M	-$5.04M	-$1.81M	-$247.00K	$19.75M
Net Income	$275.27M	-$228.36M	-$137.45M	-$352.61M	$679.00M
Diluted EPS	0.92	-0.89	-0.53	-1.24	2.07
Diluted Shares	305.94M	255.53M	259.27M	283.25M	329.75M

OSCR Balance Sheet statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Cash & Equivalents	$2.24B	$2.60B	$2.15B	$2.77B	$4.81B
Receivables	$763.44M	$745.71M	$697.47M	$598.46M	$951.71M
Total Assets	$5.84B	$6.38B	$5.75B	$6.33B	$9.29B
Long-Term Debt	$299.75M	$299.94M	$686.29M	$430.10M	$430.88M
Total Debt	$299.75M	$299.94M	$686.29M	$430.10M	$430.88M
Total Liabilities	$4.51B	$5.22B	$4.72B	$5.34B	$7.62B
Retained Earnings	-$2.58B	-$2.80B	-$2.94B	-$3.29B	-$2.62B
Shareholders' Equity	$1.33B	$1.16B	$1.02B	$977.65M	$1.66B

OSCR Cash Flow statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Operating Cash Flow	$878.54M	$509.07M	-$964.66M	$671.90M	$2.62B
Capital Expenditure	-$9.03M	-$9.28M	-$9.01M	-$9.06M	-$8.79M
Free Cash Flow	$869.52M	$499.79M	-$973.66M	$662.84M	$2.61B
Depreciation & Amortisation	$6.73M	$6.97M	$7.31M	$7.88M	$7.02M
Stock-Based Compensation	$24.98M	$24.11M	$20.48M	$18.09M	$15.97M
Investing Cash Flow	-$174.23M	-$168.21M	$150.08M	-$48.71M	-$590.25M
Financing Cash Flow	$4.87M	$22.13M	$364.03M	$8.17M	-$3.60M
Net Change in Cash	$709.19M	$362.99M	-$450.54M	$631.37M	$2.03B

Market Snapshot

About

Oscar Health, Inc. is a technology-focused health insurance company offering individual and small group health plans through the Affordable Care Act marketplace and Medicare Advantage, leveraging data and design to improve member experience.